Concepedia

Publication | Closed Access

A phase I trial of a rhenium 186‐labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: Toxicity and clinical response

DOI

54

Citations

0

References

1994

Year

Allan J. Jacobs, Mehmet F. Fer, Fu‐Min Su, Hazel B. Breitz, John F. Thompson, Henry Goodgold, Joanna M. Cain, JAMES HEAPS, P L Weiden
International Journal of Gynecology & Obstetrics

Abstract

This immunoconjugate can be administered intraperitoneally with acceptable toxicity and produces objective responses after a single dose in patients with minimal objective disease.